40 research outputs found
Effect of Lacidipine on Blood Pressure and Endothelial Function in Mild-to-Moderate Essential Hypertension Patients With Diabetes in Korea
Antidepressants and Mood Stabilizers: Novel Research Avenues and Clinical Insights for Bipolar Depression
The concept of the bipolar-spectrum and of mixed features being a bridge between major depressive disorders and bipolar disorders (BDs) has become increasingly important in mood-disorder diagnoses. Under these circumstances, antidepressants (ADs) and mood stabilizers (MSs) should be used with caution in the treatment of major depressive episodes (MDEs) and to obtain long-term stability in BDs. Before treating MDEs, screening tools, specific symptom evaluation and medical history should be used to distinguish between bipolarity and mixed features in patients for whom AD monotherapy may present a risk. In these patients, a combination of ADs plus MSs or atypical antipsychotics is recommended, rather than AD monotherapy. Studies evaluating MSs for bipolar depression suggest that lamotrigine is the most reliable treatment and lithium has modest effects; there is a lack of clear evidence regarding the efficacy of valproate and carbamazepine. Recently, significant progress has been made with respect to the pathophysiology of mood disorders and the application of potential biomarkers. There is an opportunity to study novel drug mechanisms through the rediscovery of fast-acting drugs such as ketamine. It is anticipated that future research developments will involve the discovery of potential targets for new drugs and their application to personalized treatments
New Animal Model of Shigellosis in the Guinea Pig: Its Usefulness for Protective Efficacy Studies
Innate Immunity Mediated by MyD88 Signal Is Not Essential for Induction of Lipopolysaccharide-Specific B Cell Responses but Is Indispensable for Protection against Salmonella enterica
The Effect of Testosterone Replacement on Sexual Function in the Elderly: A Systematic Review and Meta-Analysis
Purpose: Healthy aging is an important concern in an aging society. Although the causal relationship between hypogonadism
and erectile dysfunction in elderly men remains unclear, many physicians have achieved positive results after implementing
exogenous testosterone supplementation therapy in patients with normal or slightly low blood testosterone. The purpose of
this study was to conduct a systematic review and meta-analysis on whether testosterone replacement therapy (TRT) could
improve sexual function in the elderly, as reported recently.
Materials and Methods: As a comprehensive literature search was performed to find articles published in PubMed, Embase,
and Cochrane databases by January 2022. The search used keywords of ‘aged’, ‘male’, ‘sexual behavior’, and ‘testosterone’.
Randomized controlled trials (RCTs) were finally selected. As the main effect variable, results of a questionnaire on sexual
function were analyzed and the effects of TRT were compared to those of placebo control.
Results: Five RCT studies were included in this meta-analysis. The overall improvement by mean difference of sexual function
for testosterone supplementation was 0.082 (95% CI: -0.049 to 0.213). In subgroup analysis, only intramuscular injection of
1,000 mg testosterone significantly improved sexual function of the elderly (0.229, 95% CI: 0.112 to 0.347). There was no
significant difference in sexual function according to testosterone dose in meta-ANOVA (p=0.957). The difference was not
statistically significant either in the meta-regression test (p=0.310). Egger’s regression coefficient test did not indicate a publication
bias (p=0.132).
Conclusions: Although our overall effect size (that is, sexual function effect of TRT) did not show a significant improvement,
the direction of improvement in erection and motivation was clearly shown. The injection formulation resulted in a significant
sexual function improvement. Since only a few RCTs were included in the analysis, more well-designed prospective
studies are needed to have a definite conclusion
MyD88 Signaling Is Not Essential for Induction of Antigen-Specific B Cell Responses but Is Indispensable for Protection against Streptococcus pneumoniae Infection following Oral Vaccination with Attenuated Salmonella Expressing PspA Antigen
TLRs directly induce innate host defense responses, but the mechanisms of TLR-mediated adaptive immunity remain subject to debate. In this study, we clarified a role of TLR-mediated innate immunity for induction of adaptive immunity by oral vaccination with a live recombinant attenuated Salmonella enteric serovar Typhimurium vaccine (RASV) strain expressing Streptococcus pneumoniae surface protein A (PspA) Ag. Of note, oral or intranasal vaccination with RASV expressing PspA resulted in identical or even significantly higher levels of PspA-specific IgG and IgA responses in the systemic and mucosal compartments of MyD88–/– mice of either BALB/c or C57BL/6 background when compared with those of wild-type mice. Although PspA-specific CD4+ T cell proliferation in the MyD88–/– mice was minimal, depletion of CD4+ T cells abolished PspA-specific IgG and IgA responses in the MyD88–/– mice of BALB/c background. Of the greatest interest, MyD88–/– mice that possessed high levels of PspA-specific IgG and IgA responses but minimal levels of CD4+ T cell responses died earlier than nonvaccinated and vaccinated wild-type mice following i.v. or intranasal challenge with virulent S. pneumoniae. Taken together, these results suggest that innate immunity activated by MyD88 signals might not be necessary for Ag-specific Ab induction in both systemic and mucosal sites but is critical for protection following oral vaccination with attenuated Salmonella expressing PspA.This work was supported by the governments of the Republic of Korea, Sweden, and
Kuwait; the Bill & Melinda Gates Foundation; National Institutes of Health Grant R01-
AI056289; and by a Korea Science and Engineering Foundation (KOSEF) grant funded
by the government of Korea (MEST) (Nos. 2007-04213 and R01-2008-000-10649-0)